Table 2.
Q-values of pathways detected by GIENA for the pancreatic cancer dataset
| Pathway | Cooperation | Competition | Redundancy | Dependency | GSA |
|---|---|---|---|---|---|
| Glycosphingolipid biosynthesis |
0.018 |
0.002 |
0.004 |
0.027 |
0.064 |
| Classic complement activation |
0.047 |
0.003 |
0.040 |
0.027 |
0.052 |
| Classic |
0.047 |
0.003 |
0.034 |
0.027 |
0.064 |
| Classic & alternative complement |
0.047 |
0.004 |
0.039 |
0.026 |
0.052 |
| ACE2 |
0.047 |
0.004 |
0.027 |
0.026 |
0.064 |
| Bisphenol A degradation |
0.049 |
0.009 |
0.048 |
0.027 |
0.064 |
| Lysine degradation |
0.037 |
0.009 |
0.040 |
0.028 |
0.061 |
| Renin-angiotensin system |
0.047 |
0.009 |
0.035 |
0.027 |
0.052 |
| Glycosphingolipid biosynthesis (neo-lactoseries) | 0.018 | 0.026 | 0.004 | 0.027 | 0.064 |
q-value < 0.01 is considered as significant, and highlighted in bold. Note none of pathways has significant q-value using GSA.